Quia Pharma AB (publ) (STO:QUIA)
Sweden
· Delayed Price · Currency is SEK 0.0078
-0.0006 (-7.14%)
May 14, 2025, 2:31 PM CET
Quia Pharma AB Revenue
In the year 2024, Quia Pharma AB had annual revenue of 460.00K SEK, down -89.48%. Quia Pharma AB had revenue of -1.90M in the half year ending December 31, 2024, a decrease of -163.72%.
Revenue
460.00K
Revenue Growth
-89.48%
P/S Ratio
30.74
Revenue / Employee
153.33K
Employees
3
Market Cap
14.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 460.00K | -3.91M | -89.48% |
| Dec 31, 2023 | 4.37M | -1.20M | -21.53% |
| Dec 31, 2022 | 5.57M | -3.16M | -36.15% |
| Dec 31, 2021 | 8.73M | 4.99M | 133.48% |
| Dec 31, 2020 | 3.74M | -727.00K | -16.28% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.24B |